exelixis inc (EXEL:NASDAQ GS)
Stelios Papadopoulos Ph.D.
Chairman of the Board and Member of Audit Committee, Exelixis, Inc.
|Age||Total Calculated Compensation||This person is connected to 100 board members in 9 different organizations across 13 different industries.|
See Board Relationships
Dr. Stelios Papadopoulos, Ph.D. is a Co-Founder of Exelixis, Inc. and has been its Chairman of the Board since January 1998. Dr. Papadopoulos is a Co-Founder of Fondation Santé and serves as its Chairman. He co-founded Cellzome Inc. in 2000 and has been its Chairman since its inception. He co-founded Cellzome AG in 2000. He is a private biotechnology investor. His career in biopharmaceuticals spans more than two decades. He served as Managing Director of Life Sciences ...
210 East Grand AvenuePhone: 650-837-7000
South San Francisco, California 94080
Board Members Memberships*
Co-Founder and Director
Former Vice Chairman and Managing Director
Co-Founder, Chairman and Member of Audit Committee
Former Co-Founder, Chairman, Chairman of Corporate Governance & Nominating Committee and Member of Compensation Committee
Director, Chairman of Nominating & Governance Committee and Member of Compensation Committee
Chairman, Member of Science & Technology Committee, Member of Audit Committee and Member of Finance Committee
Chairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
New York University
New York University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|James A. Bianco M.D.||Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee|
CTI BioPharma Corp.
|Ali Fattaey Ph.D.||Chief Executive Officer, President and Director|
|Robert I. Blum||Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern|
|Raul R. Rodriguez||Chief Executive Officer, President and Director|
Rigel Pharmaceuticals, Inc.
|Myung-Joong Cho Ph.D.||Founder, Chief Executive Officer and President|
|--||Compensation as of Fiscal Year 2013.|